Go Pro

Horizon Kinetics Medical ETF Rating

$35.49 +0.12 (+0.34%)
As of 07/24/2026

Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2026)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

MEDX Aggregate Rating

Moderate Buy
2.67

Holdings in MEDX have an aggregate rating of Moderate Buy based on 403 analyst ratings issued in the past year covering 22 companies (79.2% of the portfolio).

MEDX Aggregate Price Target

$35.49
High Prediction$35.49
Average Prediction$35.49
Low Prediction$35.49

Holdings in MEDX have an aggregate price target of $35.49 and a range of $35.49 to $35.49 covering 22 companies (79.2% of the portfolio).

MEDX Consensus Ratings of Holdings

Strong Buy
1 Strong Buy rating(s)
Buy
0 Buy rating(s)
Moderate Buy
14 Moderate Buy rating(s)
Hold
6 Hold rating(s)
Reduce
1 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Horizon Kinetics Medical ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 22 MEDX Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
18.68%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,196.18
+0.9%
3.7458 of 5 stars
2.87$1,283.64 7.3%31
9.29%
AbbVie Inc. stock logo
ABBV
AbbVie
$259.10
+0.8%
4.3517 of 5 stars
2.84$268.10 3.5%25
5.71%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$263.43
+1.6%
4.2857 of 5 stars
2.80$265.30 0.7%25
5.69%
Alkermes plc stock logo
ALKS
Alkermes
$52.89
-0.2%
2.2192 of 5 stars
2.72$52.50 -0.7%18
4.82%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$62.05
+0.9%
4.0572 of 5 stars
2.37$61.25 -1.3%19
4.17%
Amgen Inc. stock logo
AMGN
Amgen
$376.04
+1.2%
4.0343 of 5 stars
2.43$356.62 -5.2%30
4.08%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$131.06
+0.4%
4.5312 of 5 stars
2.70$133.94 2.2%20
3.34%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$271.77
+1.1%
4.6062 of 5 stars
2.85$452.13 66.4%26
3.24%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$56.55
+1.2%
3.6333 of 5 stars
2.77$95.90 69.6%22
3.10%
Biogen Inc. stock logo
BIIB
Biogen
$202.19
+0.8%
3.9201 of 5 stars
2.53$220.57 9.1%32
3.10%
Pfizer Inc. stock logo
PFE
Pfizer
$24.53
-1.9%
4.2981 of 5 stars
2.19$28.50 16.2%21
2.83%
GSK PLC Sponsored ADR stock logo
GSK
GSK
$51.38
+1.3%
3.2149 of 5 stars
2.20$53.00 3.2%10
2.44%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$46.54
-2.1%
3.3742 of 5 stars
2.58$67.78 45.6%19
2.33%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$656.01
+0.6%
4.4529 of 5 stars
2.70$787.88 20.1%27
1.30%
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$25.10
-3.1%
2.5366 of 5 stars
2.64$46.85 86.6%14
1.08%
Galectin Therapeutics Inc. stock logo
GALT
Galectin Therapeutics
$3.47
+0.6%
2.3511 of 5 stars
1.67$11.00 217.0%3
0.81%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$10.73
-3.3%
3.6615 of 5 stars
2.30$20.19 88.1%23
0.72%
Sandoz Group AG Sponsored ADR stock logo
SDZNY
Sandoz Group
$77.92
-1.5%
1.7581 of 5 stars
3.504
0.68%
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
$9.80
+0.9%
3.8509 of 5 stars
2.5010
0.67%
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
$5.18
-3.4%
2.8624 of 5 stars
2.50$14.30 176.1%8
0.65%
Replimune Group, Inc. stock logo
REPL
Replimune Group
$9.70
-7.3%
1.2888 of 5 stars
2.00$8.86 -8.7%9
0.43%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$2.60
-4.8%
3.085 of 5 stars
2.57$5.40 107.7%7

This page (NASDAQ:MEDX) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners